JPMorgan Chase & Co’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-5
| Closed | -$63 | – | 6370 |
|
2025
Q1 | $63 | Buy |
+5
| New | +$63 | ﹤0.01% | 6062 |
|
2024
Q4 | – | Sell |
-2
| Closed | -$30 | – | 6418 |
|
2024
Q3 | $30 | Hold |
2
| – | – | ﹤0.01% | 6129 |
|
2024
Q2 | $28 | Hold |
2
| – | – | ﹤0.01% | 6098 |
|
2024
Q1 | $27 | Sell |
2
-8,103
| -100% | -$109K | ﹤0.01% | 6115 |
|
2023
Q4 | $109K | Buy |
8,105
+8,104
| +810,400% | +$109K | ﹤0.01% | 4734 |
|
2023
Q3 | $12 | Sell |
1
-20,710
| -100% | -$249K | ﹤0.01% | 6303 |
|
2023
Q2 | $280K | Buy |
20,711
+20,709
| +1,035,450% | +$280K | ﹤0.01% | 4092 |
|
2023
Q1 | $0 | Buy |
2
+1
| +100% | – | ﹤0.01% | 5955 |
|
2022
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 5736 |
|
2022
Q2 | – | Sell |
-4
| Closed | – | – | 5731 |
|
2022
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 5820 |
|
2021
Q4 | $0 | Buy |
4
+3
| +300% | – | ﹤0.01% | 5790 |
|
2021
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 5627 |
|
2021
Q2 | – | Sell |
-3
| Closed | – | – | 5541 |
|
2021
Q1 | $0 | Buy |
3
+2
| +200% | – | ﹤0.01% | 5297 |
|
2020
Q4 | $0 | Sell |
1
-1
| -50% | – | ﹤0.01% | 4965 |
|
2020
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 4878 |
|
2020
Q2 | $0 | Buy |
+2
| New | – | ﹤0.01% | 4824 |
|
2019
Q4 | – | Sell |
-2
| Closed | – | – | 4777 |
|
2019
Q3 | $0 | Buy |
2
+1
| +100% | – | ﹤0.01% | 4834 |
|
2019
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4866 |
|
2019
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4904 |
|
2017
Q1 | – | Sell |
-20
| Closed | – | – | 4470 |
|
2016
Q4 | $0 | Buy |
+20
| New | – | ﹤0.01% | 4491 |
|
2016
Q2 | – | Sell |
-11
| Closed | – | – | 4292 |
|
2016
Q1 | $0 | Buy |
+11
| New | – | ﹤0.01% | 4206 |
|
2014
Q1 | – | Sell |
-26,510
| Closed | -$542K | – | 3532 |
|
2013
Q4 | $542K | Buy |
+26,510
| New | +$542K | ﹤0.01% | 3165 |
|